Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.
about
The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancerPharmacologic interventions for the prevention and treatment of retinopathy of prematurityω-3 Fatty Acids and Cardiovascular Diseases: Effects, Mechanisms and Dietary RelevanceAdvances in Our Understanding of Oxylipins Derived from Dietary PUFAsPreservation of metabolic flexibility in skeletal muscle by a combined use of n-3 PUFA and rosiglitazone in dietary obese miceHuman Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic MetabolismThe role of long chain fatty acids and their epoxide metabolites in nociceptive signalingRole of the modulation of CYP1A1 expression and activity in chemopreventionComparison of free serum oxylipin concentrations in hyper- vs. normolipidemic menModulation of blood oxylipin levels by long-chain omega-3 fatty acid supplementation in hyper- and normolipidemic menOral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin patternCytochrome P450-generated metabolites derived from ω-3 fatty acids attenuate neovascularizationRationally designed multitarget agents against inflammation and pain.Increase of EPA-derived hydroxy, epoxy and dihydroxy fatty acid levels in human plasma after a single dose of long-chain omega-3 PUFA.Phase 1 study of the effect of icosapent ethyl on warfarin pharmacokinetic and anticoagulation parameters.Effect of concomitant icosapent ethyl (eicosapentaenoic acid ethyl ester) on the pharmacokinetics of atorvastatin.Dietary Omega-3 Polyunsaturated Fatty Acids Prevent Vascular Dysfunction and Attenuate Cytochrome P4501A1 Expression by 2,3,7,8-Tetrachlorodibenzo-P-Dioxin.n-3 polyunsaturated fatty acids and mechanisms to mitigate inflammatory paracrine signaling in obesity-associated breast cancer.Comparison of the effects of long-chain omega-3 fatty acid supplementation on plasma levels of free and esterified oxylipinsCaenorhabditis Elegans Mutants Predict Regulation of Fatty Acids and Endocannabinoids by the CYP-35A Gene Family.Lipoxins as biomarkers of lupus and other inflammatory conditionsCYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.A protective lipidomic biosignature associated with a balanced omega-6/omega-3 ratio in fat-1 transgenic miceCurrent and emerging strategies for the treatment and management of systemic lupus erythematosus based on molecular signatures of acute and chronic inflammation(n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?Dietary n-6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain.Cytochrome P450 Oxidase 2C Inhibition Adds to ω-3 Long-Chain Polyunsaturated Fatty Acids Protection Against Retinal and Choroidal Neovascularization.Transcriptome-based identification of antioxidative gene expression after fish oil supplementation in normo- and dyslipidemic men.Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors.ω-3 and ω-6 long-chain PUFAs and their enzymatic metabolites in neovascular eye diseases.Omega-3 fatty acid supplementation and cardiovascular disease.Stress response pathways protect germ cells from omega-6 polyunsaturated fatty acid-mediated toxicity in Caenorhabditis elegans.Omega-3 Fatty acids and vitamin d in cardiology.Selective Inhibition of Bakuchicin Isolated from Psoralea corylifolia on CYP1A in Human Liver MicrosomesEffect of fish oil on monoepoxides derived from fatty acids during cardiac surgeryFatty acid-regulated transcription factors in the liver.Cytochrome P450 2C8 ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--brief reportInvolvement of free radicals and oxidative stress in NAFLD/NASH.Icosapent ethyl: a review of its use in severe hypertriglyceridemia.A defect in the activities of Δ and Δ desaturases and pro-resolution bioactive lipids in the pathobiology of non-alcoholic fatty liver disease.
P2860
Q21090644-E4203C0C-55FD-4079-8941-7FDF6864175CQ26772889-A26E55C8-CC33-41E7-8D6E-CE05B13C3984Q26782277-E5F22AE6-5827-456C-A9EF-DD09A903D1E4Q27014988-F9E93A71-E179-4428-97AA-B46041480458Q27322378-E9393C5F-7952-4CBA-BF49-276B36066FADQ27676875-6D131FD0-5F75-41A6-9297-5A6962296F4CQ28248377-E78D37B8-791A-41AC-8BBC-B411F8C45193Q28307748-ECD85A26-6DF8-4C7F-A4EA-109E159BB08FQ28387829-BA6E0DE4-8DF1-43F3-8525-EA48357AAC2DQ28392212-ADD13B1C-044C-44D3-BE57-4BCEDCE4C007Q28397238-4664DF2A-B06B-4558-81F6-3EEB555FFE90Q30583016-8F856CDA-C11B-49E4-82FF-B60EF9D5AD7DQ33960685-D9350ED5-FD94-4E44-BE1A-7CFB766F3D23Q34231280-67AC73A3-7361-4C9E-94C8-321D0F827635Q34416861-CC6442BF-0401-42FA-8536-C3A298E4D82BQ34451932-B3CED156-598D-4FA4-B6CF-DC3BD298B55BQ34536466-CAC2AFE0-6835-435C-97E9-F551A61BF8E4Q34577978-37D7A0B2-B9EC-4A17-AD95-269B1863D9C9Q34587774-557D5D68-DB09-46B3-8981-26DF6E4F4CACQ35026072-E9318F1F-E1F0-48F6-A041-984E4A5C5B72Q35044584-132973A0-11B1-48E5-BBC2-00BFAC98EE8EQ35086490-F1C541EE-DFC8-453C-8F6A-2F1671CEAE76Q35156337-78C58E84-6FF0-4409-8A64-828972CB112DQ35557372-9E63BEDC-CD4E-43AF-96C7-B0CB249EBA5BQ35753222-AAE9880A-07E1-4AFF-918C-B934FB0B4106Q35812881-EEDFE6DC-3727-49FF-AB15-0B2CDD25B5BFQ36078137-DB662D94-7129-4E3B-B09D-4C8FD9EE99DAQ36127724-A3B222E0-7318-48D1-B04A-5D030E7CCE54Q36294936-708DA86E-9AA1-4969-937C-01318EC3C3DBQ36374238-4D95092E-4BEF-405A-A0DA-CB2E3AC7521FQ36387184-8FA1B5D4-5D19-4FAA-AB23-4920342B849BQ36428195-96043FB8-B7ED-44C8-8690-AF85630E6319Q36546551-9EEE72A4-0CD4-44A1-8D12-E4171F3D9EF9Q36605392-0BB9EA1F-5D96-4A60-87D6-4D02114F7CB1Q36617491-35C39F2C-32BA-4513-B58E-1CC333703254Q37613511-57CF1043-7062-4E9E-9F80-8F8BC2D5F635Q37733656-7BC8AF96-A49B-4F6D-BD76-EE9CC82B0010Q38134169-EFC23134-D32D-48CA-B98E-933B1D18A63EQ38271868-7243D802-E9AB-4969-89B0-2F44CA6E3359Q39096535-8D6BBC2C-AA9E-4594-942E-5C6F7DDCA5F0
P2860
Cytochrome P450-dependent metabolism of omega-6 and omega-3 long-chain polyunsaturated fatty acids.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@ast
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@en
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@nl
type
label
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@ast
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@en
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@nl
prefLabel
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@ast
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@en
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@nl
P2093
P1476
Cytochrome P450-dependent meta ...... n polyunsaturated fatty acids.
@en
P2093
Anne Konkel
Cosima Arnold
Robert Fischer
Wolf-Hagen Schunck
P304
P356
10.1016/S1734-1140(10)70311-X
P577
2010-05-01T00:00:00Z